Charles River Laboratories | Eigenkapital Und Reserven



Equity Capital And Reserves Veränderung Datum
Agilent USD 6.03B 129M 2025-01
Align Technology USD 3.85B 92.37M 2024-12
Bio-Rad Laboratories USD 6.57B 918.56M 2024-12
Bruker USD 1.8B 28M 2024-12
Cardinal Health USD -2991000000 286M 2024-12
Charles River Laboratories USD 3.46B 320.77M 2024-12
Cigna USD 41.03B 1.06B 2024-12
CVS Health USD 75.56B 616M 2024-12
Danaher USD 49.54B 1.76B 2024-12
Dentsply International USD 1.94B 549M 2024-12
Elevance Health USD 41.32B 2.56B 2024-12
Galapagos EUR 2.9B 34.37M 2024-12
Hologic USD 4.77B 356.7M 2024-12
Humana USD 16.38B 1.19B 2024-12
Illumina USD 2.37B 248M 2024-12
Incyte USD 3.45B 276.41M 2024-12
IQVIA Holdings USD 6.07B 900M 2024-12
Laboratory Of America USD 8.05B 118M 2024-12
Lonza CHF 9.33B 23M 2024-12
McKesson USD -3084000000 67M 2024-12
Merck EUR 29.99B 1.66B 2024-12
Mettler Toledo International USD -126890000 27.46M 2024-12
Novartis USD 44.05B 605M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
Quest Diagnostics USD 6.78B 143M 2024-12
Revvity USD 7.67B 254.83M 2024-12
Thermo Fisher Scientific USD 49.58B 592M 2024-12
United Therapeutics USD 6.44B 343.1M 2024-12
UnitedHealth USD 92.66B 1.88B 2024-12
Walgreens Boots Alliance USD 7.11B 2.83B 2025-02
Waters USD 1.83B 225.41M 2024-12
West Pharmaceutical Services USD 2.68B 69.8M 2024-12



Charles River Laboratories Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.